The immunosuppressive surface ligand CD200 augments the metastatic capacity of squamous cell carcinoma. | Cancer Res;70(7): 2962-72, 2010 Apr 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

The immunosuppressive surface ligand CD200 augments the metastatic capacity of squamous cell carcinoma.

Stumpfova, Magda; Ratner, Desirée; Desciak, Edward B; Eliezri, Yehuda D; Owens, David M.

Affiliation

Stumpfova M; Departments of Pathology, Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA.

Cancer Res ; 70(7): 2962-72, 2010 Apr 01.

Article in En | MEDLINE | ID: mdl-20332223

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Squamous Cell / Antigens, CD Limits: Animals / Female / Humans Language: En Journal: Cancer Res Year: 2010 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Squamous Cell / Antigens, CD Limits: Animals / Female / Humans Language: En Journal: Cancer Res Year: 2010 Document type: Article Affiliation country: Country of publication: